Of note, the RASSF1A methylation exhibited better sensitivity and specificity (52.0% and 91.5%, respectively) in distinguishing HCC from chronic hepatitis B compared with AFP (48.0% and 73.9%, respectively) [117]. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.